Literature DB >> 33732804

Rapid Genome Engineering of Pseudomonas Assisted by Fluorescent Markers and Tractable Curing of Plasmids.

Daniel C Volke1, Nicolas T Wirth1, Pablo I Nikel1.   

Abstract

Precise genome engineering has become a commonplace technique for metabolic engineering. Also, insertion, deletion and alteration of genes and other functional DNA sequences are essential for understanding and engineering cells. Several techniques have been developed to this end (e.g., CRISPR/Cas-assisted methods, homologous recombination, or λ Red recombineering), yet most of them rely on the use of auxiliary plasmids, which have to be cured after the editing procedure. Temperature-sensitive replicons, counter-selectable markers or repeated passaging of plasmid-bearing cells have been traditionally employed to circumvent this hurdle. While these protocols work reasonably well in some bacteria, they are not applicable for other species or are time consuming and laborious. Here, we present a fast and versatile protocol of fluorescent marker-assisted genome editing in Pseudomonas putida, followed by clean curing of auxiliary plasmids through user-controlled plasmid replication. One fluorescent marker facilitates identification of genome-edited colonies, while the second reporter enables detection of plasmid-free bacterial clones. Not only is this protocol the fastest available for Pseudomonas species, but it can be easily adapted to any type of genome modifications, including sequence deletions, insertions, and replacements. Graphical abstract: Rapid genome engineering of Pseudomonas with curable plasmids.
Copyright © 2021 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Genome engineering; Gram-negative bacteria; Metabolic engineering; Pseudomonas; Synthetic biology; Synthetic plasmid replication

Year:  2021        PMID: 33732804      PMCID: PMC7952922          DOI: 10.21769/BioProtoc.3917

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  10 in total

1.  'Touchdown' PCR to circumvent spurious priming during gene amplification.

Authors:  R H Don; P T Cox; B J Wainwright; K Baker; J S Mattick
Journal:  Nucleic Acids Res       Date:  1991-07-25       Impact factor: 16.971

2.  The revisited genome of Pseudomonas putida KT2440 enlightens its value as a robust metabolic chassis.

Authors:  Eugeni Belda; Ruben G A van Heck; Maria José Lopez-Sanchez; Stéphane Cruveiller; Valérie Barbe; Claire Fraser; Hans-Peter Klenk; Jörn Petersen; Anne Morgat; Pablo I Nikel; David Vallenet; Zoé Rouy; Agnieszka Sekowska; Vitor A P Martins Dos Santos; Víctor de Lorenzo; Antoine Danchin; Claudine Médigue
Journal:  Environ Microbiol       Date:  2016-04-28       Impact factor: 5.491

3.  Touchdown PCR for increased specificity and sensitivity in PCR amplification.

Authors:  Darren J Korbie; John S Mattick
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

4.  Engineering multiple genomic deletions in Gram-negative bacteria: analysis of the multi-resistant antibiotic profile of Pseudomonas putida KT2440.

Authors:  Esteban Martínez-García; Víctor de Lorenzo
Journal:  Environ Microbiol       Date:  2011-08-24       Impact factor: 5.491

5.  Software-supported USER cloning strategies for site-directed mutagenesis and DNA assembly.

Authors:  Hans Jasper Genee; Mads Tvillinggaard Bonde; Frederik Otzen Bagger; Jakob Berg Jespersen; Morten O A Sommer; Rasmus Wernersson; Lars Rønn Olsen
Journal:  ACS Synth Biol       Date:  2014-05-21       Impact factor: 5.110

6.  Genetic system for reversible integration of DNA constructs and lacZ gene fusions into the Escherichia coli chromosome.

Authors:  R Platt; C Drescher; S K Park; G J Phillips
Journal:  Plasmid       Date:  2000-01       Impact factor: 3.466

7.  A Post-translational Metabolic Switch Enables Complete Decoupling of Bacterial Growth from Biopolymer Production in Engineered Escherichia coli.

Authors:  Gonzalo Durante-Rodríguez; Víctor de Lorenzo; Pablo I Nikel
Journal:  ACS Synth Biol       Date:  2018-10-22       Impact factor: 5.110

8.  Refactoring the Embden-Meyerhof-Parnas Pathway as a Whole of Portable GlucoBricks for Implantation of Glycolytic Modules in Gram-Negative Bacteria.

Authors:  Alberto Sánchez-Pascuala; Víctor de Lorenzo; Pablo I Nikel
Journal:  ACS Synth Biol       Date:  2017-02-09       Impact factor: 5.110

9.  Accelerated genome engineering of Pseudomonas putida by I-SceI-mediated recombination and CRISPR-Cas9 counterselection.

Authors:  Nicolas T Wirth; Ekaterina Kozaeva; Pablo I Nikel
Journal:  Microb Biotechnol       Date:  2019-03-12       Impact factor: 5.813

10.  Synthetic control of plasmid replication enables target- and self-curing of vectors and expedites genome engineering of Pseudomonas putida.

Authors:  Daniel C Volke; Laura Friis; Nicolas T Wirth; Justine Turlin; Pablo I Nikel
Journal:  Metab Eng Commun       Date:  2020-03-19
  10 in total
  4 in total

1.  Modular (de)construction of complex bacterial phenotypes by CRISPR/nCas9-assisted, multiplex cytidine base-editing.

Authors:  Daniel C Volke; Román A Martino; Ekaterina Kozaeva; Andrea M Smania; Pablo I Nikel
Journal:  Nat Commun       Date:  2022-05-31       Impact factor: 17.694

2.  Oligomerization engineering of the fluorinase enzyme leads to an active trimer that supports synthesis of fluorometabolites in vitro.

Authors:  Tiia Kittilä; Patricia Calero; Folmer Fredslund; Phillip T Lowe; David Tezé; Manuel Nieto-Domínguez; David O'Hagan; Pablo I Nikel; Ditte H Welner
Journal:  Microb Biotechnol       Date:  2022-01-27       Impact factor: 6.575

3.  Combinatorial pathway balancing provides biosynthetic access to 2-fluoro-cis,cis-muconate in engineered Pseudomonas putida.

Authors:  Nicolas T Wirth; Pablo I Nikel
Journal:  Chem Catal       Date:  2021-11-18

4.  Developing a CRISPR-assisted base-editing system for genome engineering of Pseudomonas chlororaphis.

Authors:  Sheng-Jie Yue; Peng Huang; Song Li; Yu-Yuan Cai; Wei Wang; Xue-Hong Zhang; Pablo I Nikel; Hong-Bo Hu
Journal:  Microb Biotechnol       Date:  2022-05-16       Impact factor: 6.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.